ethyl methanesulfonate has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuji, H; Holtz, R; Lewandowski, N; Murphy, SP; Tomasi, TB | 1 |
| Adamson, DJ; Bowdon, BJ; Shealy, YF; Wheeler, GP | 1 |
2 other study(ies) available for ethyl methanesulfonate and Leukemia L 1210
| Article | Year |
|---|---|
DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.
Topics: 5' Untranslated Regions; Animals; Antineoplastic Agents, Alkylating; B-Lymphocytes; Cell Differentiation; Clone Cells; DNA Methylation; Ethyl Methanesulfonate; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, MHC Class II; Histocompatibility Antigens Class II; Hybridomas; Leukemia L1210; Mice; Mice, Inbred DBA; Nuclear Proteins; Promoter Regions, Genetic; Trans-Activators; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2002 |
Chemical properties and biological effects of 2-haloethyl sulfonates.
Topics: Alkanesulfonates; Alkylating Agents; Animals; Antineoplastic Agents; Cross-Linking Reagents; DNA; Ethyl Methanesulfonate; In Vitro Techniques; Leukemia L1210; Mice; Structure-Activity Relationship | 1984 |